Literature DB >> 30208326

TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses.

Lin Luo1, Adam A Wall1, Samuel J Tong1, Yu Hung1, Zhijian Xiao1, Abdullah A Tarique2, Peter D Sly2, Emmanuelle Fantino2, María-Paz Marzolo3, Jennifer L Stow4.   

Abstract

The multi-ligand endocytic receptor, low-density lipoprotein-receptor-related protein 1 (LRP1), has anti-inflammatory roles in disease. Here, we reveal that pathogen-activated Toll-like receptors (TLRs) activate LRP1 in human and mouse primary macrophages, resulting in phosphorylation of LRP1 at Y4507. In turn, this allows LRP1 to activate and recruit the guanosine triphosphatase (GTPase), Rab8a, with p110γ/p101 as its phosphatidylinositol 3-kinase (PI3K) effector complex. PI3Kγ is a known regulator of TLR signaling and macrophage reprogramming. LRP1 coincides with Rab8a at signaling sites on macropinosomal membranes. In LRP1-deficient cells, TLR-induced Rab8 activation is abolished. CRISPR-mediated knockout of LRP1 in macrophages alters Akt/mTOR signaling and produces a pro-inflammatory bias in cytokine outputs, mimicking the Rab8a knockout and PI3Kγ-null phenotype. Thus, TLR-LRP1 crosstalk activates the Rab8a/PI3Kγ complex for reprogramming macrophages, revealing this as a key mechanism through which LRP1 helps to suppress inflammation.
Copyright © 2018 The University of Queensland. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; LRP1; PI3Kγ; Rab8a; Toll-like receptor; crosstalk; inflammation; mTOR; macrophage; polarization

Mesh:

Substances:

Year:  2018        PMID: 30208326     DOI: 10.1016/j.celrep.2018.08.028

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  26 in total

1.  Detecting Endogenous Rab8 Activation.

Authors:  Samuel J Tong; Richard M Lucas; Zhijian Xiao; Lin Luo; Jennifer L Stow
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.

Authors:  Steven L Gonias
Journal:  Am J Physiol Cell Physiol       Date:  2021-08-18       Impact factor: 5.282

3.  Gβγ is a direct regulator of endogenous p101/p110γ and p84/p110γ PI3Kγ complexes in mouse neutrophils.

Authors:  Natalie K Rynkiewicz; Karen E Anderson; Sabine Suire; Daniel M Collins; Eleftherios Karanasios; Oscar Vadas; Roger Williams; David Oxley; Jonathan Clark; Len R Stephens; Phillip T Hawkins
Journal:  Sci Signal       Date:  2020-11-03       Impact factor: 8.192

4.  Guanine nucleotide exchange factors activate Rab8a for Toll-like receptor signalling.

Authors:  Samuel J Tong; Adam A Wall; Yu Hung; Lin Luo; Jennifer L Stow
Journal:  Small GTPases       Date:  2019-03-07

5.  Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors.

Authors:  Zied Gaieb; Kaelin D Fleming; Manoj K Rathinaswamy; Chiara Borsari; Noah J Harris; Brandon E Moeller; Matthias P Wymann; Rommie E Amaro; John E Burke
Journal:  Elife       Date:  2021-03-04       Impact factor: 8.140

Review 6.  The role of PI3Kγ in the immune system: new insights and translational implications.

Authors:  Stephen M Lanahan; Matthias P Wymann; Carrie L Lucas
Journal:  Nat Rev Immunol       Date:  2022-03-23       Impact factor: 53.106

Review 7.  Maximizing insights from monogenic immune disorders.

Authors:  Anis Barmada; Anjali Ramaswamy; Carrie L Lucas
Journal:  Curr Opin Immunol       Date:  2021-10-22       Impact factor: 7.486

Review 8.  Salmonella Typhimurium and inflammation: a pathogen-centric affair.

Authors:  Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2021-05-19       Impact factor: 78.297

Review 9.  Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.

Authors:  Nicola Potere; Marco Giuseppe Del Buono; Adolfo Gabriele Mauro; Antonio Abbate; Stefano Toldo
Journal:  Front Cardiovasc Med       Date:  2019-04-26

Review 10.  LDL receptor-related protein 1 and its interacting partners in tissue homeostasis.

Authors:  Anja Jaeschke; David Y Hui
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.